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ABSTRACT Long-term treatment with a drug to a G-protein–coupled receptor (GPCR) often leads to receptor-mediated
desensitization, limiting the therapeutic lifetime of the drug. To better understand how this therapeutic window might be
controlled, we created a mechanistic Monte Carlo model of the early steps in GPCR signaling and desensitization. Using this
model we found that the rates of G-protein activation and receptor phosphorylation can be partially decoupled by varying the
drug-receptor dissociation rate constant, koff, and the drug’s efﬁcacy, a. The maximum ratio of G-protein activation to receptor
phosphorylation (GARP) was found for drugs with an intermediate koff value and small a-value. Changes to the cellular
environment, such as changes in the diffusivity of membrane molecules and the G-protein inactivation rate constant, affected
the GARP value of a drug but did not change the characteristic shape of the GARP curve. These model results are examined in
light of experimental data for a number of GPCRs and are found to be in good agreement, lending support to the idea that the
desensitization properties of a drug might be tailored to suit a speciﬁc application.
INTRODUCTION
As a general rule, ligands cause both receptor-mediated
signaling and signal desensitization. In the case of G-protein–
coupled receptors (GPCRs), a ligand signals by activating
a receptor, which in turn activates a second messenger
(G-protein) inside the cell. By holding the receptor in the
active state, the ligand also targets the receptor for phos-
phorylation—a key ﬁrst step in the desensitization pathway.
In this work we use Monte Carlo simulations of ligand-
induced GPCR signaling and desensitization to learn how
these two processes are related and suggest new directions
for drug design. Historically drug development has focused
primarily on ﬁnding drugs that cause a response in the short
term, viewing longer-term, drug-induced desensitization as a
side effect. However, receptor activation and desensitization
are intimately related processes that must both be considered
when developing a useful drug. For example, the highly
potent m-opioid receptor agonist etorphine is not a medically
useful drug because it can only be used a few times before
the body becomes desensitized to the drug (Yu et al., 1997).
By better understanding how drug properties affect signaling
and desensitization, we hope to guide drug development
efforts toward new drugs with fewer side effects and a
greater range of therapeutic applications.
In a classical view of drug action, receptor signaling and
desensitization are simply related; however, experimental
data in a variety of systems indicate that the relationship is
more complex. According to the classical view, any changes
to a ligand that increase its ability to signal would also
increase the amount of receptor phosphorylation caused by
the ligand. In contrast, experimental measurements of
activation and desensitization for the three different receptor
systems shown in Fig. 1 indicate that this simple relationship
does not hold for a number of well-studied cases. Similarly,
ligand-induced activation and desensitization are not simply
related in the dopamine D1 (Balmforth et al., 1990; Barton
and Sibley, 1990) and N-formyl peptide receptor systems
(Riccobene et al., 1999), although in these systems the
deviation is less severe. Therefore, in many receptor systems,
ligand-induced signaling is a poor predictor of the ligand’s
desensitization ability.
If receptor signaling is not the primary determinant of
ligand-induced desensitization, then what is? For a given
signaling pathway in a particular cell type, the ability to
differentially regulate activation and desensitization must
rest with the ligand itself. Here we test the hypothesis that the
ligand’s binding kinetics and ability to activate a receptor
conspire to differentially regulate desensitization and
activation. This connection suggests a relatively simple
approach to decoupling desensitization and activation via
changes in ligand-speciﬁc properties.
Mechanism of GPCR signaling
and desensitization
For GPCRs, the mechanism of ligand-induced activation and
desensitization can be divided into the three steps shown in
Fig. 2. In the ﬁrst step (Fig. 2 A), a ligand binds to the
receptor to stabilize a speciﬁc receptor conformation. A
common approximation is to assume that the receptor rapidly
oscillates between an inactive conformation (R) and an
active conformation (R*). In this view, a ligand signals by
biasing the receptor to spend more time in a particular
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conformation. This ligand-induced bias is controlled by the
drug’s conformational selectivity factor, a, which roughly
corresponds to a drug’s efﬁcacy and will ﬁgure prominently
in this work.
In the second step (Fig. 1 B), the active receptor binds to
and activates a G-protein in the cell membrane. In the
inactive state, G-proteins exist as a GDP-bound trimer. Upon
activation by a receptor, the G-protein exchanges GDP for
GTP and breaks into two signaling subunits, Ga-GTP and
Gbg. In most G-protein species, the active Ga-GTP protein is
thought to dissociate from the membrane to activate
cytosolic targets (Evanko et al. 2000). Due to an intrinsic
GTPase activity of the Ga subunit, Ga-GTP reverts to an
inactive Ga-GDP which then can rebind with the membrane
bound Gbg subunit to recover the inactive G-protein. Using
this mechanism the cell is able to detect and amplify small
signals and also reset when the signal is removed.
In the third step (Fig. 1 C), the active receptor is
phosphorylated and targeted for desensitization. The active
Gbg subunit is able to recruit a receptor kinase to the
membrane. Once attached to the membrane, the receptor
kinase can phosphorylate receptors and in doing so target
them for arrestin binding and eventual internalization
(Krupnick and Benovic, 1998). It is believed that only
receptors in the active conformation are phosphorylated
because other, inactive receptor species present in the cell
membrane that are also subject to phosphorylation are not
internalized when their ligand is absent (Bunemann et al.,
1999). Other parallel desensitization pathways involving
PKA and PKC also exist (Chuang et al., 1996), but these
pathways are poorly understood and are thought to play a
less important role in desensitization and therefore are not
included in our analysis.
GPCR desensitization as a spatially dependent
and discrete process
The early steps of desensitization are likely best represented
as spatially dependent and discrete. Because many of the
reactions that mediate desensitization take place within the
membrane, reaction rates depend not only on the intrinsic
interactions between species, but also on the rates of diffusion
to bring species together. In practice, diffusion limitations
often play a dominant role in limiting the overall reaction rate
between species within the membrane, adding an inherently
spatial component to the desensitization reaction (Lauffen-
burger and Linderman, 1993). As a result, in systems where
diffusion is slow, reactions tend to depend strongly on the
local rather than global concentration of each species.
When diffusion rates are limiting, desensitization also
becomes a more discrete process. Because slow diffusion
rates limit the pool of reactive species to a small local area,
the total number of reactive species drops. At these low
numbers, the discrete identity of each protein plays a more
signiﬁcant role. For example, if diffusion is slow, then the
recruitment of one receptor kinase to the cell membrane will
strongly affect the phosphorylation rates of nearby receptors,
but will not affect the phosphorylation rates of distant
receptors. Because proteins are discrete, there is a ﬁnite
probability that the receptor kinase will phosphorylate all of
the local receptors and have no further effects.
From a modeling perspective, the discrete and spatially
dependent phenomena associated with desensitization can
be included by using a Monte Carlo (MC) model, as is done
in this work. This MC model simulates the reaction and
diffusion events of discrete particles as a stochastic process.
It is important to note that although MC models can simu-
late discrete and spatially dependent reactions, they can also
model conditions where diffusion is not limiting and
particles behave in a more continuous way. Thus, MCmodels
provide a mechanistic technique to simulate reactions under
broader conditions than can be described using classical
mass action kinetics, and as such are expected to better
represent biological reactions within the cell membrane.
An MC simulation of a similar local, discrete behavior has
been demonstrated for G-protein activation (Mahama and
Linderman, 1994). These simulations examined the impor-
tance of ligand movement among surface receptors, some-
times termed ‘‘switching’’ (Stickle and Barber, 1989). To
understand switching, consider the three ligand-binding
regimes described in Fig. 3. At one extreme, a ligand
molecule binds a receptor with a very small ligand
dissociation rate constant (koff), thereby forming a long-
lived receptor-ligand complex that exhibits nearly no
switching (Fig. 3 A). Under these conditions, the receptor
activates all local G-proteins to form a diffusion-limited zone
FIGURE 1 Comparison of activation and de-
sensitization proﬁles for a variety of drugs
(circles) in three different receptor systems. (a)
b2-adrenergic receptors in a reconstituted mem-
brane system (Benovic et al., 1988). (b) Dopamine
D1A receptor in C-6 glioma cells (Lewis et al.,
1998). (c) m-Opioid receptors in Xenopus oocytes
(Yu et al., 1997).
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that is depleted of inactive (or ‘‘activate-able’’) G-proteins
and enriched in Gbg surrounding the receptor. At the other
extreme, a ligand molecule binds receptors with a large koff
value, thereby forming short-lived receptor-ligand com-
plexes that exhibit strong switching behavior (Fig. 3 C).
Under these conditions, ligand movement among receptors
allows smaller, more homogeneous Gbg enrichment zones to
form. Between these two extremes are ligands that bind with
an intermediate value of koff and exhibits some switching
behavior (Fig. 3 B). Ligands in this intermediate state exhibit
a distribution of local Gbg enrichment zones, which will
become important later when describing how the receptor
phosphorylation rate changes with koff.
Previous work has indicated that increased ligand switch-
ing will lead to an increase in overall G-protein activation
(Mahama and Linderman, 1994; Shea and Linderman,
1997). By rapidly switching receptors from the active to
inactive states, ligands with large koff values cause less
G-protein activation per ligand binding event, but more
activation overall due to the reduced inﬂuence of diffusion
limitations surrounding the receptor. These simulation
results have been corroborated by some experimental
ﬁndings (Mahama and Linderman, 1995; Stickle and Barber,
1989, 1992), although more experimental work needs to be
done to establish their generality.
We hypothesize that switching effects also play a
prominent role in controlling receptor desensitization. Like
G-protein activation, receptor phosphorylation is governed
by reactions between membrane-bound species and as such
is likely to be diffusion-limited. In addition, G-protein acti-
vation and receptor desensitization are sequentially linked
because the G-protein must be activated before receptor
kinase can be recruited to the membrane (see Fig. 2).
Therefore, changes in G-protein activation should affect
receptor phosphorylation, although not necessarily at the
same time scale.
Previous models of desensitization did not include discrete
reactions or spatial effects, and as such were unable to ad-
dress the effects of the ligand dissociation rate constant that
governs switching. For example, a model of desensitization
using a simpliﬁed ordinary differential equation model of
receptor activation and desensitization suggested that the
conformational selectivity factor, a, plays a dominant role in
controlling both G-protein activation and desensitization
(Riccobene et al., 1999). However, in systems such as the
dopamine D1A receptor shown in Fig. 1 B, G-protein acti-
vation and receptor desensitization are not easily related and
as such cannot be simply explained by the effect of a alone.
FIGURE 2 Three processes that affect GPCR desensitization. (a) Re-
ceptors sense the environment via ligand binding. The ratio of ligand-bound
receptors in the active state vs. inactive state is determined by the receptor
activation equilibrium constant, KACT, and the ligand-speciﬁc conforma-
tional selectivity factor, a. (b) Active receptor conformations can bind to and
activate the G-protein trimer. Because the Ga subunit possesses an intrinsic
GTPase activity, with time the subunit will cleave GTP into GDP, thereby
allowing the inactive Ga subunit to recombine with Gbg to recover the
inactive G-protein. (c) Receptor desensitization is initiated by RK binding
to the active Gbg subunit of the G-protein. This complex can then
phosphorylate the active receptor, targeting the receptor for internalization
and desensitization. Note that the ligand binding and G-protein activation
properties of the receptor are the same independent of the receptor’s
phosphorylation state.
FIGURE 3 The process formation of enrichment zones of Gbg as a
function of the koff value of a ligand. (a) At low koff values, a low
concentration ligand will tend to fully activate only a few receptors. This
local activation will cause a signiﬁcant depletion of inactive G-proteins and a
concomitant enrichment in Gbg around a few receptors, although leaving
most receptors untouched. (b) Intermediate koff values cause the Gbg
enrichment zones to become somewhat more homogeneous, but smaller. (c)
Large koff values result in a more homogeneous distribution of smaller Gbg
enrichment zones surrounding the receptor. Note that Gbg enrichment zones
correspond to inactive G-protein depletion zones because inactive G-
proteins are consumed to generate Gbg.
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We propose that phosphorylation-mediated desensitiza-
tion and G-protein activation can be differentially regulated
in some systems by the interaction of the ligand-speciﬁc con-
formational selectivity factor, a, and the ligand dissociation
rate constant, koff. The extent of this differential regulation
depends on the cellular environment. This relationship will
ﬁrst be explored using a computational model of receptor
activation and desensitization and results will then be com-
pared to experimental data.
METHODS
To accurately represent the spatial, discrete, and transient dynamics that
inﬂuence GPCR signaling and desensitization, we chose to use a kinetic
two-dimensional MC model. The signaling and desensitization reactions
used in the model are shown in Fig. 2. The simulation contained eleven
distinct species: R, Rp, LR, LRp, LR*, LRp*, G, Ga-GTP, Ga-GDP, Gbg,
and Gbg-RK. Each species is described in more detail in Table 1.
Although most species in the model are membrane-bound, Ga-GTP and
Ga-GDP are cytosolic. As a result, the location of these two species was not
explicitly followed, but instead it was assumed that these proteins were added
to a general cytosolic pool. This approximation was made because diffusion
through the three-dimensional cytosol should be more rapid than comparable
diffusion along the membrane and as such can be assumed to be nearly
instantaneous. Receptor kinase, or RK, technically represents a third cyto-
solic species; however, the dynamics of RK regulation and the concentration
of receptor-accessible RK in the cell are currently not known. Therefore, it is
assumed that RK comes from a constant concentration pool and thus changes
to its population size are not explicitly tracked in the model.
The parameters describing the base case for the reaction and diffusion
events of the simulation are listed in Table 2. For the simulation, the kinetic
reaction rates were converted into reaction probabilities using standard
techniques (Mahama and Linderman, 1994; Shea and Linderman, 1997).
Some of these physical parameters are available directly from the literature,
whereas others had to be estimated. For example, the receptor kinase
association rate constant, kf-RK, is an estimated composite rate term that
includes the product of the intrinsic association rate between RK and Gbg
times the constant concentration of the RK pool. The value of kf-RK was
estimated to be on the same order as the Ga-Gbg association rate constant,
kd, because in both cases proteins are recruited from the cytosol to bind with
Gbg in the cell membrane. The receptor kinase dissociation rate constant,
kr-RK, was estimated by assuming that the receptor kinase binds to Gbg with
a high equilibrium afﬁnity. Few diffusion coefﬁcients are known speciﬁcally
for GPCRs, although diffusion coefﬁcients in the range of 1011 to 109 cm2
s1 have been reported for membrane receptors in general (e.g., Barak et al.,
1997; Gennis, 1989; Ljungquist-Hoddelius et al., 1991; Niswender et al.,
1985; Smith et al., 1999).
Future experimental work will help to reﬁne the estimates. Note that
G-protein activation and receptor phosphorylation are assumed to be
diffusion-limited reactions (Shea and Linderman, 1997), and as such are
modeled as collision-coupled.
The rate of interconversion between active and inactive receptor states
takes place at a short time scale relative to desensitization, and as such was
assumed to be in equilibrium, in agreement with experimental observations
(Jensen et al., 2001). The equilibrium between active and inactive receptor
states was deﬁned by the composite equilibrium constant aKACT, where a
is the ligand-speciﬁc conformational selectivity factor and KACT is the
equilibrium ratio of active to inactive receptors when no ligand is present.
The conformational selectivity factor, a, represents a measure of a drug’s
intrinsic efﬁcacy with increasing a values corresponding to increasing
positive agonism (Kenakin, 2002). Receptors not bound to ligand were
assumed to be inactive, corresponding to a physiologically realistic case of
negligible constitutive signaling. In agreement with experimental ﬁndings
(Jin et al., 2000), ligand-bound phosphorylated and nonphosphorylated
receptors are assumed to signal with equal activity.
TABLE 1 Identities and locations of the species used in
the model
Species Name Description Location
R Inactive receptor membrane
Rp Phosphorylated receptor membrane
LR Ligand bound receptor membrane
LRp Ligand bound phosphorylated receptor membrane
LR* Active ligand bound receptor membrane
LRp* Active ligand bound phosphorylated
receptor
membrane
G Inactive G-protein trimer membrane
GaGTP Active a subunit of the G-protein cytosol
GaGDP Inactive a subunit of the G-protein cytosol
Gbg Active bg subunit of the G-protein membrane
GbgRK bg subunit bound to receptor kinase membrane
Note that it is assumed that unbound receptors are always inactive, whereas
ligand-bound receptors are in a rapid equilibrium between active and
inactive states.
TABLE 2 Parameters used in the model
Constant Description Value
L Ligand concentration Varied to maintain a receptor occupancy of 2.5%
kon Ligand association rate constant 108 M1 s1 (Lauffenburger and Linderman, 1993)
koff Ligand dissociation rate constant Varied from 1 to 10,000 s1
KACT Receptor activation equilibrium constant 106
a Conformational selectivity factor Varied from 105 to ‘
ki G-protein inactivation rate constant 1 s1 (Shea et al., 2000; Thomsen and Neubig, 1989)
kd Inactive G-protein association rate constant 1000 s1 (#/cell)1 (Shea et al., 2000)
kr–RK Receptor kinase dissociation rate constant 100 s1
kf–RK Receptor kinase association rate constant 1000 s1
D Receptor and G-protein diffusivity in the membrane 1011 cm2 s1 (Barak et al., 1997; Gennis, 1989;
Ljungquist-Hoddelius et al., 1991; Niswender et al., 1985; Smith et al., 1999)
All parameters are taken from the literature except for the receptor kinase association and disassociation rate constants, both of which are unknown. These
values are representative for many signaling systems; however, the given references contain citations to experimental values for speciﬁc systems. Note that
here the conformational selectivity factor (a) only affects the receptor conformation and not the ligand binding rates to ensure that the ligand-receptor
dissociation rate and receptor activation can be controlled independently.
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In a living cell, receptor phosphorylation would eventually lead to
receptor internalization and desensitization (Krupnick and Benovic, 1998).
However, these later desensitization events would take place at a much
longer time scale, and as such are not explicitly modeled here. Instead, it is
assumed that the rate of receptor phosphorylation is proportional to the
desensitization rate.
In every simulation, the ligand concentration is varied to maintain an
average value of 2.5% receptor–ligand occupancy independent of the
ligand’s dissociation and association rate constants. The ligand concen-
tration was set according to the relationship
½L ¼ koffkon
f
ð1  f Þ ;
where f is the fraction of receptors bound to ligand at equilibrium. Therefore
to maintain an average of 2.5% of receptors bound to ligand, f ¼ 0.025. By
specifying ligand occupancy this way, it is possible for the instantaneous
ligand occupancy to change over the course of the simulation due to the
stochastic nature of the model; however, the average receptor occupancy
will remain constant.
The simulations were run following a discrete Monte Carlo approach.
Physical space was divided into a 3000 3 3000 triangular mesh with
periodic boundary conditions. Membrane proteins had a diameter of two
grid spacings, with each grid spacing corresponding to a physical distance of
;2 nm. All simulations were run with 50 receptors and 500 G-proteins,
consistent with experimentally observed protein densities (Rousseau et al.,
1997; Stickle and Barber, 1989). Time was divided into discrete units shorter
than the time required for the fastest event to take place—thereby ensuring
that all events take place with a probability <1.
At each time step, a protein was chosen at random and allowed to attempt
any of its actions in a random order. The success of the action, such as
diffusion or reaction, was determined by calculating the probability of that
event occurring in the given time step and comparing that probability to a
randomly generated value. Reactions were allowed to take place if less than
two grid spacings separated the edges of the proteins. Note that reactions
between cytosolic and membrane-bound species are not constrained by the
lattice spacing interaction radius because the cytosolic species have no
explicit position. The probability of a diffusion event is proportional to the
likelihood of a protein with a diffusion coefﬁcient, D, moving one lattice
spacing in a single time step. If a diffusion event was accepted within the
time step, then the protein was moved one grid spacing in a random
direction. If the new site was unoccupied, then the move was made;
otherwise, the move was canceled and not retried. If the chosen protein is a
cytosolic species, then the diffusion event is ignored.
Initial rates of G-protein activation and receptor desensitization were
calculated from average measurements of initial rates. To gather initial rates,
the simulation was started with all nonphosphorylated receptors and inactive
G-proteins and then run for a small number of iterations (3000) cor-
responding to between 16 and 60 seconds, depending on the parameters
chosen. The value of 3000 iterations was found to be sufﬁciently long that
receptor phosphorylation events were observed, although short enough to
gather nonsaturated initial rate data. The initial G-protein activation rate was
measured as the slope of the total number of collisions between inactive
G-proteins (G) with active receptors (LR* and LRp*) as a function of time.
Similarly, the initial rate of receptor phosphorylation was measured as the
slope of the total number of collisions between active, unphosphorylated
receptors (LR*) with membrane bound receptor kinase complexes (Gbg-RK)
as a function of time. Linear least squares regression was used to obtain
average rates using data from 1000 to 3000 runs per condition. In general,
the assumption of a linear initial rate was excellent for the G-protein
activation rate (r2 values > 0.95) and adequate for receptor phosphorylation
rate (r2 values > 0.8).
The relative G-protein activation rate and receptor phosphorylation rate
were compared in a ratio that we have termed the GARP ratio. The GARP
ratio is deﬁned as the initial rate of G-protein activation divided by the initial
rate of receptor phosphorylation for a given set of model parameters. GARP
values are similar to the relative agonist signaling vs. endocytosis measured
experimentally (Whistler et al., 1999) except GARP only follows events at
the earliest stages of signal transduction.
Using this model, experiments were run in which a subset of the system
parameters was changed to assess its impact on signaling and desensitiza-
tion. In all cases, the ligand concentration, L, was varied to maintain a
constant receptor occupancy level of 2.5%, similar to the physiological
levels of many drugs in the body. Because the ligand occupancy was held
constant by changing the ligand concentration, the ligand-receptor
association rate constant (kon) was not changed. For each condition,
measurements were made for ligand dissociation rate constant (koff) values
ranging from 1 to 10000 s1. Simulations were run to see the effect of the
conformational selectivity factor (a), diffusivity (D), G-protein inactivation
rate constant (ki), and receptor kinase association rate constant (kf-RK).
These simulations were able to show the effect of ligand-speciﬁc parameters
(a and koff) and how these behaviors changed with changes in the cellular
signaling machinery (D, ki, and kf-RK).
Simulations were written in Cþþ and run on a cluster of Apple
Macintosh G4 machines. Each simulated condition took;9 h to gather 1000
runs on a single machine. The simulation source code is available upon
request from the authors.
RESULTS
Here we demonstrate that changes in ligand-speciﬁc and cell-
speciﬁc properties differentially affect GPCR signaling and
desensitization, suggesting that signaling and desensitization
can be decoupled in some systems.
Effects of ligand properties koff and a
Two important parameters that describe the interaction of a
ligand with a G-protein coupled receptor are the ligand-
receptor dissociation rate constant, koff, and the conforma-
tional selectivity factor, a. Here we report the effects of both
of these parameters on G-protein activation and receptor
phosphorylation.
As expected, changes in ligand properties change the
ligand’s ability to signal via G-proteins in the model (Fig. 4
A). Model results agree with experimental data showing that
increasing efﬁcacy (a) results in increased G-protein
activation (Kenakin, 2002). This increase in G-protein
activation due to increased a approaches a limit, however,
because at most a receptor can be 100% active—meaning
that every encounter between the receptor and an inactive G-
protein causes the G-protein to become active. Similarly,
increases in koff also result in increased G-protein activation,
as predicted by previous theoretical and experimental work
on ligand switching (Mahama and Linderman, 1994; Shea
and Linderman, 1997).
The effects of individual ligand properties on the receptor
phosphorylation rate have not been described before, and
when simulated yield the surprising results shown in Fig. 4
B. In general, increasing a results in an increased phos-
phorylation rate for any koff value. This ﬁnding makes sense
in light of the increased G-protein activation and hence
receptor kinase recruitment to the membrane that accom-
panies increases in a, and is in agreement with the previous
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modeling work in the area (Riccobene et al., 1999). In
contrast, however, increases in koff do not always lead to an
increase in the receptor phosphorylation rate. This effect is
particularly evident at lower a values, where the phosphor-
ylation rate can be clearly seen to pass through a minimum at
an intermediate koff value.
The reason that intermediate values of koff can cause a
minimum in receptor phosphorylation can be understood by
examining the spatial distribution of signaling and desensi-
tization processes operating in the cell. The gray enrichment
zones shown in Fig. 3 show how the concentration of Gbg
and hence Gbg-RK is distributed as a function of koff. At low
koff values, Gbg-RK forms a large island around the ligand-
bound receptor (as in Fig. 3 A), causing the few receptor-
ligand complexes to become phosphorylated with nearly
100% probability. As koff increases, the size of the Gbg-RK
island decreases resulting in a lower probability of a ligand-
bound receptor becoming phosphorylated (Fig. 3 B).
However, at sufﬁciently high koff values (Fig. 3 C), the
increase in the number of receptors that can be phosphory-
lated and the total number of Gbg-RK present in the system
begins to play a dominant role, resulting in a net increase in
receptor phosphorylation.
Said another way, at intermediate values of koff, the ligand
remains bound to the receptor for long enough to activate
G-proteins, but often not long enough for the active G-pro-
teins to recruit a receptor kinase to the membrane and
phosphorylate the receptor. Therefore, at intermediate values
of koff receptor phosphorylation is minimized.
The relative effects of changing ligand properties on
signaling and desensitization can be examined by plotting
the GARP values as in Fig. 4 C. By directly comparing the
G-protein activation rate and receptor phosphorylation rate,
we see a clear maximum at intermediate koff values and low
a values. From a drug design standpoint, this maximum
predicts that for each value of efﬁcacy there exists an optimal
koff that will maximize signaling although minimizing
desensitization.
Effects of cell properties ki, D, and kf-RK
Although a ligand’s GARP value is clearly dependent on the
identity of the ligand, cell-speciﬁc parameters are also likely
to inﬂuence a ligand’s signaling and desensitization proﬁle.
These differences associated with the cell could help to
explain why in some systems activation and desensitization
are proportional, whereas in other systems they are not.
To explore the effect of different cell-speciﬁc properties,
the following three parameters were independently varied:
the G-protein inactivation rate constant, ki; the diffusion
coefﬁcient, D; and the receptor kinase association rate
constant, kf-RK. In each case, a ligand’s GARP value was
calculated for a range of cell-speciﬁc parameter values and
a range of koff values to see how the parameter affected
G-protein activation and receptor desensitization. In each
simulation, one reference case using the parameters listed in
Table 2 is included for comparison. The results are plotted in
Fig. 5.
As shown in Fig. 5 A, increasing the G-protein
inactivation rate constant, ki, increases a ligand’s GARP
value. The reason for this increase is that a larger ki value
results in a shorter Gbg lifetime, which in turn limits the
distance that a Gbg can diffuse before becoming inactivated.
Because Gbg is responsible for recruiting receptor kinase to
the membrane, a shorter Gbg lifetime translates to a shorter
receptor kinase lifetime and therefore less desensitization.
Changing the diffusion coefﬁcient, D, of the proteins
within the membrane also affects a ligand’s GARP value as
shown in Fig. 5 B. Physiologically, the diffusion coefﬁcient
could change due to changes in membrane lipid composition
or changes in receptor localization—both of which would
depend on the speciﬁc receptor type and cellular environ-
ment. Increasing the diffusion coefﬁcient causes the system
to be better mixed, resulting in both increased G-protein
activation and receptor phosphorylation rates (data not
shown). The G-protein activation rate increases because in
a better-mixed system, local depletion zones like those
FIGURE 4 Effects of ligand dissociation rate constant, koff, and conformational selectivity factor, a, on the initial rates of G-protein activation and receptor
phosphorylation. Values of a ¼ 105, 106, 107, and ‘ represent ligand-receptor complexes that are active 10%, 50%, 90%, and 100% of the time, respectively.
Note that the a ¼ 107 and a ¼ ‘ curves nearly overlap. In all simulations, 2.5% of receptors are occupied by ligand. The data in (a) and (b) are combined into
(c) to directly show the relationship between the G-protein activation rate and receptor phosphorylation rate, or GARP value. Parameter values not mentioned
are listed in Table 2.
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shown in Fig. 3 play a less signiﬁcant role. Similarly, the
receptor phosphorylation rate increases because in a better-
mixed system, a receptor kinase has access to more
receptors. However, increasing the diffusion coefﬁcient has
a disproportionately larger effect on the receptor phosphor-
ylation rate, resulting in a lower GARP value for most of the
koff values tested. The reason for this bias is that under low
diffusion conditions, the mean time between receptor-G-
protein collisions is long, reducing the probability that the
two-step process of G-protein activation and subsequent
receptor phosphorylation will complete before the ligand
dissociates. In contrast, G-protein activation only depends on
a single receptor-G-protein collision to take place and there-
fore is less sensitive to the effects of changing the diffusion
coefﬁcient. Interestingly, at high koff values (;104 s1), the
GARP value of the better-mixed system exceeds that of the
less well-mixed system. This crossover may be explained
by noting that at high diffusion coefﬁcient values, the
theoretical maximum number of G-proteins that can travel to
a receptor to be activated is higher.
Finally, Fig. 5 C shows that decreasing the receptor kinase
association rate constant, kf-RK, increases a drug’s GARP
value. A smaller kf-RK results in fewer receptor kinase
proteins on the membrane and thus a reduced probability
of receptor phosphorylation and a higher GARP value.
Simulations also demonstrated that changing the receptor
kinase dissociation rate constant, kr-RK, reduces a drug’s
GARP value by the same mechanism (data not shown).
Physiologically, the value of kf-RK could change with
receptor localization or the total concentration of receptor
kinase proteins near the membrane. Although the values of
kf-RK and kr-RK are currently unknown, the simulation results
indicate that changes in these parameters only scale the
GARP proﬁle, but do not change the qualitative behavior.
Therefore, these ﬁndings reassure us that our choice of kf-RK
and kr-RK values is not critical to the characteristic behavior
of the system.
DISCUSSION
This modeling work was motivated by the observation that
G-protein activation and receptor phosphorylation are
sometimes but not always proportional (see Fig. 1). We
speculated that this lack of correlation in some systems takes
place because ligands differ not only in their efﬁcacy (a in
our model), but also in their dissociation rate constant, koff.
The results in Figs. 4 and 5 show for the ﬁrst time that
changes in koff can alter the receptor phosphorylation rate
and hence alter the level of desensitization induced by the
ligand. Furthermore, our results indicate that by varying a
and koff, the G-protein activation and receptor phosphor-
ylation rates can be partially decoupled. These results have
implications for our general understanding of receptor
dynamics as well as for drug design. In the following
sections we discuss the general structure of the relationship
between activation and desensitization and provide two
examples from the literature that demonstrate this behavior.
Finally we discuss how our ﬁndings could be used to design
drugs with tailored desensitization proﬁles.
Conserved relationship between GPCR
activation and desensitization
Our simulation results demonstrate that GPCR activation and
desensitization are related in a complicated, yet predictable,
way. Therefore using our simulation results we attempted to
discover a characteristic dynamic that describes the relation-
ship between activation and desensitization in general terms.
Because of the structure of the model, an analytical solution
was not possible, forcing us to rely on patterns observed in
the numerical results alone.
When the simulation results are replotted as activation rate
vs. desensitization rate and only the koff value of the drug is
varied, we obtain a characteristic s-shaped activation vs.
desensitization curve shown in Fig. 6 A. Increasing the a-
value of a drug ﬂattens and shifts the curve to the right,
whereas changes to cellular parameters cause the curve to
stretch or shift. However, in all cases tested, the underlying
characteristic curve remains.
The s-curve can be divided into three distinct regimes,
each corresponding to a different range of koff values. In
region I, koff values are low, corresponding to ligands with a
long bound lifetime on a single receptor as is illustrated in
Fig. 3 A. In this region, activation and desensitization both
increase with increasing koff. Physically, ligands in region I
have a sufﬁciently long ligand-receptor half-life that the
G-protein activation rate comes to steady state and nearly
FIGURE 5 Effects of cell properties on G-
protein activation and receptor phosphorylation
rates. (a) G-protein inactivation rate constant,
ki, varied from 0.1–10 s1. (b) Diffusion
coefﬁcient, D, varied from 1010–1011 cm2/s.
(c) Receptor kinase association rate constant,
kf-RK, varied from 100–1000 s1. Parameter
values not mentioned are listed in Table 2.
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every ligand-bound receptor becomes phosphorylated before
the ligand dissociates. At the opposite extreme is region III,
corresponding to ligands with large koff values. For ligands
in this region, the ligand-receptor half-life is sufﬁciently
short that diffusion-limited Gbg enrichment zones surround-
ing the receptor are minimized as illustrated in Fig. 3 C.
Therefore, region III ligands tend to cause less phosphor-
ylation per receptor, but visit more receptors and activate
overall more G-proteins. As a result, the large koff value of
ligands in region III tends to cause an increase in both
G-protein activation and phosphorylation as was discussed
earlier in the results section.
Most interestingly, ligands in region II have an inter-
mediate koff value, which allows them to cause dispro-
portionately more G-protein activation than receptor
phosphorylation. Physically, ligands in this region are able
to bind for a sufﬁciently long time to activate nearly all of the
local G-proteins surrounding the receptor (Fig. 3 B), but
often not long enough to phosphorylate the receptor. By
sitting at the tipping point in koff between G-protein
activation and receptor phosphorylation, the drug is able to
maximize its signal although minimizing its desensitization.
Note that this same tipping point can be observed in Fig. 4 C
at a koff value of 2500 s1. The location of this tipping point
in koff varies as a function of the ligand conformational
selectivity factor, a, and the cell speciﬁc parameters as was
described in the results section.
To explore how changes in a and cell-speciﬁc parameters
affect the characteristic relationship between activation and
desensitization, additional simulations were run using a
variety of ligands (black dots) under two different cellular
conditions (Fig. 6, B and C). Ligands of constant a are
linked by a solid line.
When diffusion is slow and the half-life of signaling
species is short, the koff value of a ligand has a greater ability
to differentially regulate activation and desensitization, as is
shown in Fig. 6 B. Under these cellular conditions, receptor
signaling events are spatially isolated. This isolation, in turn,
makes the cell permissive to ligand switching effects like the
behavior illustrated in Fig. 3.
In contrast, when diffusion is fast and the half-life of
signaling species is long, the koff value of a ligand regulates
both activation and desensitization in a similar way (Fig. 6
C). These cellular conditions tend to distribute signaling
events over many receptors, thereby reducing the ability of
ligand switching to exploit the delay between G-protein
activation and receptor kinase recruitment. As a result, these
cellular conditions reduce the ability of ligand switching to
differentially regulate activation and desensitization.
Under both cellular conditions, increasing the a-value of a
ligand ﬂattened and shifted the curve to the right as is shown
in Fig. 6, B and C. In some cases only part of the curve is
present in the range of koff values tested. For example, in Fig.
6 C, at low a-values only region II is represented. In other
cases, the curve is sufﬁciently compressed that region II
vanishes completely and only regions I and III are present
(Fig. 6C, right two lines). Similarly, in Fig. 6B, the left-most
curve shows only regions II and III, but has lost region I.
The trends in the model predictions made in Fig. 6 are in
qualitative agreement with the experimental results in Fig. 1.
Experimentally, it has been found that G-protein activation
and desensitization are not simply correlated for at least two
receptor systems (see Fig. 1, B and C). Similarly, our
simulations show that only under limited conditions would
one expect to ﬁnd a simple relationship between activation
and desensitization. For example, imagine testing a small
number of ligands from Fig. 6 B, each with its own a and koff
values, and plotting their activation vs. desensitization
proﬁles together as was done in Fig. 1. The resulting plot
may show a general correlation between activation and
FIGURE 6 Activation vs. desensitization simulation results for ligands with a variety of different dissociation rate constants (koff) and efﬁcacy (a) values.
(a) Characteristic activation vs. desensitization response curves as affected by a and koff. The response behavior for a range of a values can be divided into
three regions: I, II, and III. (b) Activation and desensitization proﬁles for cellular conditions that favor signal localization (D ¼ 1011 cm2 s1; ki ¼ 10 s1;
kf-RK¼ 100 s1). (c) Activation and desensitization proﬁle for cellular conditions that do not favor signal localization (D¼ 1010 cm2 s1; ki¼ 0.1 s1; kf-RK¼
1000 s1). In both (b) and (c), dots represent individual ligand parameter value states and solid lines connect ligands of constant a (105, 106, and 107) tested
over koff values ranging from 1 to 10000 s1. Note that the simulations do not predict that activation and desensitization are proportional.
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desensitization, but this correlation would be poor and would
likely include examples of drugs that exhibit disproportion-
ately more activation than desensitization. However, under-
lying the simulation results and likely the experimental
results, a family of nonlinear s-curves that precisely de-
scribes how activation and desensitization respond to a and
koff is illustrated in Fig. 6 A. Therefore in many cases the
presence of these s-curves prevents us from drawing a simple
linear relationship between signaling and desensitization,
from both theoretical and experimental data.
Inside-out control of desensitization via ki
An intriguing possibility is that by regulating its G-protein
inactivation rate constant, ki, the cell itself could dynam-
ically alter the GARP value of a ligand as demonstrated by
the modeling results in Fig. 5 A. By changing its ki value, the
cell could exert a form of inside-out control on its signaling
environment.
One way the cell could vary its ki value is by regulating
the activity of regulators of G-protein signaling (RGS)
proteins inside the cell. RGS proteins bind directly to
Ga-GTP and act as GTPase-activating proteins to attenuate
GPCR signaling, thereby increasing the apparent ki value
inside the cell (Neubig and Siderovski, 2002). Changes in
RGS expression and localization have been detected for a
number of receptor systems. For example, work with the
endothelin-1 receptor has indicated that RGS4 and RGS16
are upregulated in response to GPCR signaling (Patten et al.,
2002). Similarly, in yeast the GPCR-mediated pheromone
response is mediated by the recruitment of RGS8 to the cell
membrane from the cytosol (Saitoh et al., 2001). These data
suggest that the cell does regulate its own ki value via RGS
proteins in response to GPCR signaling.
By dynamically regulating the RGS concentration, the cell
would not only attenuate the short-term signal caused by a
ligand, but according to the simulation results in Fig. 5 A,
would also cause a disproportionately large change in the
receptor phosphorylation rate caused by the ligand. This
modeling prediction has been observed experimentally. For
example, measurements of membrane depolarization in
response to GPCR signaling have shown that the expression
of RGS4 causes little change in the maximal signal, but
can signiﬁcantly reduce ligand-mediated desensitization
(Chuang et al., 1998). This change in signaling and desen-
sitization corresponds to an increased apparent GARP value
upon RGS expression, which is in agreement with the sim-
ulation results in Fig. 5 A. Similar examples of differential
regulation of GPCR signaling and desensitization by RGS
proteins have been demonstrated for the m-opioid receptor
system (Garzon et al., 2001).
By differentially regulating the GPCR signaling and
desensitization via RGS proteins, the cell could control its
dynamic signaling range via an inside-out mechanism. In the
classic view of GPCR signaling, the ligand alone governs
desensitization whereas the cell is a passive detector.
However, by regulating the activity of RGS proteins, the
cell may be able to affect how it detects a ligand, perhaps
changing a highly desensitizing ligand into a ligand that
induces little desensitization.
m-Opioid receptor and the morphine paradox
G-protein signaling and receptor desensitization have been
well studied in the m-opioid receptor system in an effort to
develop better pain management medications. Of particular
relevance to this work, the m-opioid agonist morphine is
unique in that it is able to elicit a signal and yet causes nearly
no receptor phosphorylation (Yu et al., 1997).
According to our simulations, morphine’s paradoxical
ability to signal with minimal desensitization is possible if
morphine is in region II of Fig. 6 A. In this state, morphine
would bind long enough to activate many G-proteins but not
long enough to cause phosphorylation of the receptor. In
agreement with this prediction, morphine is known to bind
weakly to the receptor (Zhang et al., 1998)—thus possibly
accounting for its disproportionately low receptor phosphor-
ylation rate.
Available data on other ligands to the m-opioid receptor
are also consistent with the model predictions. Data for three
such ligands are shown in Table 3, along with data on
morphine. All of these ligands exhibit the general trend that
at low koff values, signaling and desensitization are both
relatively high, whereas at high koff values, signaling is
favored over desensitization. This ﬁnding is in agreement
with the s-curve behavior in which drugs with a low koff
value correspond to region I drugs, whereas drugs with an
intermediate to high koff value correspond to region II drugs.
It is possible that region III drugs do not appear in this assay
TABLE 3 Relationship between activation, desensitization, and ligand dissociation rate for four common ligands to the
m-opioid receptor
Ligand G-protein activation
Ligand dissociation
rate
Receptor
desensitization References
morphine intermediate fast low Blake et al., 1997; Rothman et al., 1995; Zhang et al., 1998
etorphine high slow high Blane et al., 1967; Rothman et al., 1995; Zhang et al., 1998
buprenorphine intermediate slow high Blake et al., 1997; Rothman et al., 1995
DAMGO high fast intermediate Scheibe et al., 1984; Tolkovsky, 1982; Yu et al., 1997
Table modiﬁed from Riccobene, 1999.
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because either the diffusion coefﬁcient in this system is large
or that the drug’s afﬁnity for the receptor is too low to be a
useful drug.
Clinical work with the m-opioid receptor by Shen and
Crain (1997) has demonstrated that coadministration of low
doses of a neutral antagonist, such as naloxone or naltrexone,
along with an agonist can cause the agonist to signal for a
longer period of time before becoming desensitized. By
blocking receptors with the neutral antagonist, Shen and
Crain (1997) have essentially reduced the receptor density in
the system without affecting the agonist dissociation rate.
This reduction in receptor density would be expected to
cause an increased isolation of signaling events, similar to
the cellular conditions presented in Fig. 6 B. The qualitative
result as predicted by the model is that adding a neutral
antagonist should distort the s-curve–type behavior of the
signal vs. desensitization proﬁle, possibly moving the
activity of the agonist to a less desensitizing region.
Impact for drug design
To include desensitization as a design criteria will require a
fundamental change in the way drug designers view their
goal. Historically drug design has focused on optimizing a
drug’s ability to signal and its potency, viewing desensitiza-
tion as an unavoidable side effect. In contrast to this view,
our simulation results indicate that desensitization can be, at
least in part, decoupled from signaling and tailored for
speciﬁc therapeutic applications. As a rule of thumb, drugs
with a lower efﬁcacy (lower a) and intermediate dissociation
rate constant (koff) will cause a disproportionately less
desensitization than activation. This combination of efﬁcacy
and dissociation may in part account for why drugs such as
morphine cause such small levels of desensitization although
still causing an appreciable signal.
However, changing a drug’s desensitization proﬁle comes
at a cost to both the drug’s absolute signaling ability and its
potency. For example, if a drug has a lower afﬁnity for its
receptor then it must be given at higher doses, possibly
leading to toxic side effects. Drug designers have historically
circumvented many toxicity issues by developing drugs that
bind tightly to the receptor, thereby permitting extremely low
effective dosages. Although this approach resulted in less
toxicity, it may have also inadvertently optimized for drugs
that cause maximal desensitization. Similarly, by reducing
the efﬁcacy of a drug (reduced a), one also reduces the
maximal ability of the drug to signal. As shown in Fig. 4, the
drugs that have the best GARP proﬁle (Fig. 4 C) mount a
modest absolute response (Fig. 4 A).
Decoupling desensitization and activation opens the
intriguing possibility of designing drugs that primarily act
by desensitizing the receptor, with their signaling ability
playing a secondary role. These drugs could ﬁnd use in
reducing the expression levels of certain receptors that are
elevated after prolonged exposure to antagonists or inverse
agonists. For example, long-term treatment of heart disease
with b2-adrenergic receptor antagonists results in upregula-
tion of the receptor, resulting in hypersensitivity to
endogenous ligands to the receptor (Strauer, 1990). Sim-
ilarly, long-term treatment of schizophrenia with antipsy-
chotics such as haloperidol has been shown to cause
upregulation of dopamine D2 receptors and an associated
hypersensitivity to dopamine (Silvestri et al., 2000). The
simulation results presented here suggest that low doses of
drugs with a low dissociation rate constant and high efﬁcacy
would cause disproportionately more desensitization than
G-protein activation. Using these desensitization drugs, it
may be possible to safely control the expression level of
certain receptor types in the body.
Together our results suggest an exciting new direction in
pharmacology in which drug-induced signaling and desensi-
tization may be controlled independently by changing drug
properties.
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